Akorn Pharmaceuticals

Akorn Investor Relations

Press Releases

Date Title  
01/09/19 Akorn Receives FDA Warning Letter Printer Friendly Version
01/08/19 Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Printer Friendly Version